ClearBridge Investments’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,172,150
| Closed | -$34.3M | – | 763 |
|
|
2024
Q1 | $34.3M | Buy |
1,172,150
+26,463
| +2% | +$813K | 0.03% | 389 |
|
|
2023
Q4 | $38.7M | Sell |
1,145,687
-3,788
| -0.3% | -$111K | 0.03% | 366 |
|
|
2023
Q3 | $35.3M | Sell |
1,149,475
-4,674
| -0.4% | -$168K | 0.03% | 355 |
|
|
2023
Q2 | $46.2M | Buy |
1,154,149
+3,581
| +0.3% | +$148K | 0.04% | 332 |
|
|
2023
Q1 | $47M | Buy |
1,150,568
+9,156
| +0.8% | +$364K | 0.04% | 324 |
|
|
2022
Q4 | $44.1M | Buy |
1,141,412
+9,881
| +0.9% | +$481K | 0.04% | 333 |
|
|
2022
Q3 | $60.2M | Buy |
1,131,531
+5,431
| +0.5% | +$302K | 0.06% | 280 |
|
|
2022
Q2 | $65.7M | Buy |
1,126,100
+447
| +0% | +$29.3K | 0.06% | 276 |
|
|
2022
Q1 | $85.9M | Buy |
1,125,653
+4,154
| +0.4% | +$277K | 0.06% | 271 |
|
|
2021
Q4 | $67.5M | Buy |
1,121,499
+1,267
| +0.1% | +$69.9K | 0.05% | 309 |
|
|
2021
Q3 | $62.7M | Sell |
1,120,232
-3,190
| -0.3% | -$184K | 0.04% | 313 |
|
|
2021
Q2 | $68.2M | Buy |
1,123,422
+2,136
| +0.2% | +$135K | 0.05% | 308 |
|
|
2021
Q1 | $78.6M | Sell |
1,121,286
-8,865
| -0.8% | -$633K | 0.06% | 266 |
|
|
2020
Q4 | $67.6M | Buy |
1,130,151
+3,891
| +0.3% | +$228K | 0.05% | 280 |
|
|
2020
Q3 | $67.7M | Buy |
1,126,260
+434
| +0% | +$25.2K | 0.06% | 241 |
|
|
2020
Q2 | $59.1M | Buy |
1,125,826
+2,264
| +0.2% | +$94.6K | 0.05% | 252 |
|
|
2020
Q1 | $37.7M | Sell |
1,123,562
-17,561
| -2% | -$730K | 0.04% | 285 |
|
|
2019
Q4 | $52M | Buy |
1,141,123
+803
| +0.1% | +$34.1K | 0.04% | 318 |
|
|
2019
Q3 | $43.4M | Buy |
1,140,320
+527
| +0% | +$21K | 0.04% | 338 |
|
|
2019
Q2 | $49.6M | Sell |
1,139,793
-9,269
| -0.8% | -$394K | 0.04% | 321 |
|
|
2019
Q1 | $43.7M | Buy |
1,149,062
+1,407
| +0.1% | +$54.9K | 0.04% | 332 |
|
|
2018
Q4 | $49.4M | Buy |
1,147,655
+27,503
| +2% | +$1.28M | 0.05% | 294 |
|
|
2018
Q3 | $55.1M | Buy |
1,120,152
+15,014
| +1% | +$649K | 0.05% | 310 |
|
|
2018
Q2 | $35.4M | Buy |
1,105,138
+12,723
| +1% | +$439K | 0.03% | 354 |
|
|
2018
Q1 | $34M | Sell |
1,092,415
-844
| -0.1% | -$30.1K | 0.03% | 356 |
|
|
2017
Q4 | $49.9M | Buy |
1,093,259
+1,139
| +0.1% | +$45.1K | 0.05% | 311 |
|
|
2017
Q3 | $41M | Sell |
1,092,120
-6,022
| -0.5% | -$242K | 0.04% | 342 |
|
|
2017
Q2 | $52.4M | Buy |
1,098,142
+10,390
| +1% | +$482K | 0.05% | 308 |
|
|
2017
Q1 | $49.6M | Buy |
1,087,752
+2,442
| +0.2% | +$106K | 0.05% | 315 |
|
|
2016
Q4 | $35.1M | Sell |
1,085,310
-1,625
| -0.1% | -$54.2K | 0.04% | 338 |
|
|
2016
Q3 | $37.2M | Buy |
1,086,935
+885
| +0.1% | +$34.7K | 0.04% | 330 |
|
|
2016
Q2 | $36.6M | Buy |
1,086,050
+3,163
| +0.3% | +$155K | 0.04% | 315 |
|
|
2016
Q1 | $57.4M | Sell |
1,082,887
-14,273
| -1% | -$835K | 0.07% | 239 |
|
|
2015
Q4 | $84.3M | Buy |
1,097,160
+273,458
| +33% | +$15.5M | 0.1% | 196 |
|
|
2015
Q3 | $33.9M | Buy |
823,702
+51,393
| +7% | +$3.15M | 0.04% | 335 |
|
|
2015
Q2 | $54.6M | Buy |
772,309
+51,801
| +7% | +$4.08M | 0.06% | 278 |
|
|
2015
Q1 | $64M | Sell |
720,508
-146,113
| -17% | -$14.8M | 0.07% | 258 |
|
|
2014
Q4 | $76.8M | Sell |
866,621
-2,136
| -0.2% | -$202K | 0.08% | 220 |
|
|
2014
Q3 | $84.2M | Buy |
868,757
+6,801
| +0.8% | +$662K | 0.09% | 199 |
|
|
2014
Q2 | $79.2M | Buy |
861,956
+235,492
| +38% | +$17.9M | 0.09% | 207 |
|
|
2014
Q1 | $43.8M | Buy |
626,464
+97,964
| +19% | +$6.66M | 0.05% | 301 |
|
|
2013
Q4 | $30.4M | Buy |
528,500
+276,883
| +110% | +$14.6M | 0.04% | 361 |
|
|
2013
Q3 | $12.1M | Buy |
+251,617
| New | +$9.17M | 0.02% | 470 |
|
Other funds holding PCRX
FCM
SIMG
